Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: Relationship between clinical features and immunohistochemical changes

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 144, Issue 1, 2009, Pages 44-47

  De Falco, Marianna ^a   Staibano, Stefania ^a   Mascolo, Massimo ^a   Mignogna, Chiara ^a   Improda, Luigi ^a   Ciociola, Francesca ^a   Carbone, Ilma F ^a   Di Lieto, Andrea ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cleavage plan; GnRH a therapy; Intraoperative blood loss; Leiomyoma pseudocapsule; Myomectomy

Indexed keywords

CD34 ANTIBODY; CYCLINE; TRIPTORELIN;

ADULT; ARTICLE; BLEEDING; CELL PROLIFERATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOMECTOMY; OPERATION DURATION; PEROPERATIVE COMPLICATION; PREMENOPAUSE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PSEUDOCAPSULE; RANDOMIZED CONTROLLED TRIAL; UTERUS MYOMA; VASCULARIZATION;

EID: 64149114577     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.02.006     Document Type: Article

References (16)

1. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Library 2007 [issue 4].
2. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
3. In: Martius H. (Ed). Trattato di Ginecologia (1953), Abruzzini Editore, Roma
4. Walocha J.A., Litwin J.A., and Miodoński A.J. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy. Hum Reprod 18 5 (2003) 1088-1093
5. De Falco M., Staibano S., Pollio F., et al. Expression of proliferating cell nuclear antigen and bcl-2 during a pseudomenopausal state induced by pre-surgical treatment of uterine leiomyomas with gonadotropin-releasing hormone analogues plus tibolone. Int J Gynecol Pathol 24 3 (2005) 286-291
6. De Falco M., Staibano S., D'Armiento F.P., et al. Pre-operative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor. J Soc Gynecol Investig 13 4 (2006) 297-303
7. Vercellini P., Trespidi L., Zaina B., Vicentini S., Stellato G., and Crosignani P.G. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 79 6 (2003) 1390-1395
8. Di Lieto A., De Falco M., Staibano S., et al. Effects of gonadotropin-releasing hormone agonists on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas. Int J Gynecol Pathol 22 4 (2003) 353-358
9. Di Lieto A., De Falco M., Pollio F., et al. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig 12 2 (2005) 123-128
10. Dubuisson J.B., Fauconnier A., Fourchotte V., Babaki-Fard K., Coste J., and Chapron C. Laparoscopic myomectomy: predicting the risk of conversion to an open procedure. Hum Reprod 16 8 (2001) 1726-1731
11. Beyth Y. Gonadotropin-releasing hormone analog treatment should not precede conservative myomectomy [letter]. Fertil Steril 53 (1990) 187-188
12. Acien P., and Quereda F. Abdominal myomectomy: results of a simple operative technique. Fertil Steril 65 (1996) 41-51
13. Sreenan J.J., Prayson R.A., Biscotti C.V., Thornton M.H., Easley K.A., and Hart W.R. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. Am J Surg Pathol 20 4 (1996) 427-432
14. Mizutani T., Sugihara A., Nakamuro K., and Terada N. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate). J Clin Endocrinol Metab 84 4 (1998) 1253-1255
15. Vu K., Greenspan D.L., Wu T.C., Zacur H.A., and Kurman R.J. Cellular proliferation, estrogen receptor, progesterone receptor, and Bcl-2 expression in GnRH agonist-treated uterine leiomyomas. Hum Pathol 29 (1998) 359-363
16. Huang S.C., Chou C.Y., Lin Y.S., et al. Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist. Am J Obstet Gynecol 177 2 (1997) 417-424